The predictive value of uric acid to albumin ratio for contrast-induced nephropathy after Percutaneous coronary intervention and the construction of clinical predictive model

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400094506

Enrollment

Unknown

Registered

2024-12-24

Start date

2025-01-01

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Does contrast-induced nephropathy occur after PCI in patients with coronary artery disease

Interventions

the CIN group and the Non-CIN group:NA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age and gender are not restricted. 2. Patients with coronary heart disease who underwent PCI. 3. Complete medical records.

Exclusion criteria

Exclusion criteria: 1. Contact with contrast agents and/or medications that affect renal function within the past week. 2. Severe heart failure or cardiogenic shock. 3. Presence of immune system disorders, severe infections, malignant tumors, hematological diseases, or severe liver dysfunction. 4. Chronic kidney disease stages 4-5.

Design outcomes

Primary

Measure	Time frame
sensitivity;specificity;	—

Countries

China

Contacts

Public ContactChen Baofeng

Yuebei People’s Hospital

aofent@126.com+86 751 6913381

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026